Pharsight

Drug Patents Expiring in 2021

1. Adasuve patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9687487 ALEXZA PHARMS Aerosol forming device for use in inhalation therapy
Oct, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) Dec 21, 2015

Drugs and Companies using LOXAPINE ingredient

Market Authorisation Date: 21 December, 2012

Treatment: NA

Dosage: POWDER;INHALATION

More Information on Dosage

ADASUVE family patents

Family Patents

2. Amondys 45 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9416361 SAREPTA THERAPS INC Splice-region antisense composition and method
May, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-347) Feb 25, 2028
New Chemical Entity Exclusivity(NCE) Feb 25, 2026

Drugs and Companies using CASIMERSEN ingredient

NCE-1 date: 25 February, 2025

Market Authorisation Date: 25 February, 2021

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

AMONDYS 45 family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Aptiom patents expiration

Can you believe APTIOM received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5753646 SUMITOMO PHARMA AM Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them
Jun, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Dosing Schedule(D-150) Aug 27, 2018
New Indication(I-715) Aug 27, 2018
New Chemical Entity Exclusivity(NCE) Nov 08, 2018

Drugs and Companies using ESLICARBAZEPINE ACETATE ingredient

NCE-1 date: 08 November, 2017

Market Authorisation Date: 08 November, 2013

Treatment: Treatment of partial-onset seizures

Dosage: TABLET;ORAL

How can I launch a generic of APTIOM before it's drug patent expiration?
More Information on Dosage

APTIOM family patents

Family Patents

4. Arnuity Ellipta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7101866 GLAXOSMITHKLINE Anti-inflammatory androstane derivative
Aug, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
M(M-290) Mar 01, 2026
New Strength(NS) May 17, 2021
New Patient Population(NPP) May 17, 2021
New Product(NP) Aug 20, 2017

Drugs and Companies using FLUTICASONE FUROATE ingredient

Market Authorisation Date: 17 May, 2018

Treatment: Indicated for the once-daily maintenance treatment of asthma as prophylactic therapy in patients aged 12 years of age and older

Dosage: POWDER;INHALATION

More Information on Dosage

ARNUITY ELLIPTA family patents

Family Patents

5. Avycaz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8178554 ALLERGAN Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
Jul, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Feb 25, 2020
New Patient Population(NPP) Dec 20, 2025
Generating Antibiotic Incentives Now(GAIN) Feb 25, 2025
New Indication(I-738) Jun 22, 2019

Drugs and Companies using AVIBACTAM SODIUM; CEFTAZIDIME ingredient

NCE-1 date: 26 February, 2024

Market Authorisation Date: 25 February, 2015

Treatment: A method of treating a bacterial infection in hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (habp/vabp) patients comprising administering an effective amount of a...

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

AVYCAZ family patents

Family Patents

6. Balcoltra patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6716814 AVION PHARMS Enhancing solubility of iron amino acid chelates and iron proteinates
Aug, 2021

(2 years ago)

Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient

Market Authorisation Date: 09 January, 2018

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of BALCOLTRA before it's drug patent expiration?
More Information on Dosage

BALCOLTRA family patents

Family Patents

7. Biktarvy patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6703396 GILEAD SCIENCES INC Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
Mar, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-256) Jun 18, 2026
M(M-82) Feb 24, 2024
M(M-305) Apr 24, 2027
New Indication(I-942) Feb 23, 2027
Orphan Drug Exclusivity(ODE-468) Feb 23, 2031
Orphan Drug Exclusivity(ODE-378) Oct 07, 2028
New Chemical Entity Exclusivity(NCE) Feb 07, 2023
New Patient Population(NPP) Jun 18, 2022

Drugs and Companies using BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE ingredient

NCE-1 date: 07 February, 2022

Market Authorisation Date: 07 October, 2021

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of BIKTARVY before it's drug patent expiration?
More Information on Dosage

BIKTARVY family patents

Family Patents

8. Breo Ellipta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7101866 GLAXO GRP LTD Anti-inflammatory androstane derivative
Aug, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) May 13, 2026
New Strength(NS) May 13, 2026
Pediatric Exclusivity(PED) Nov 13, 2026
M(M-202) May 15, 2020
New Product(NP) May 10, 2016
New Chemical Entity Exclusivity(NCE) May 10, 2018
New Indication(I-708) Apr 30, 2018

Drugs and Companies using FLUTICASONE FUROATE; VILANTEROL TRIFENATATE ingredient

NCE-1 date: 13 November, 2025

Market Authorisation Date: 12 May, 2023

Treatment: Indicated for the once-daily inhaled treatment for asthma in adults aged 18 years and older

Dosage: POWDER;INHALATION

More Information on Dosage

BREO ELLIPTA family patents

Family Patents

9. Brilinta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7265124 ASTRAZENECA Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound
Jul, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-848) Nov 05, 2023
M(M-283) May 09, 2025
Pediatric Exclusivity(PED) Nov 09, 2025
New Indication(I-851) May 28, 2023
New Strength(NS) Sep 03, 2018
New Indication(I-714) Sep 03, 2018
New Chemical Entity Exclusivity(NCE) Jul 20, 2016

Drugs and Companies using TICAGRELOR ingredient

NCE-1 date: 09 November, 2024

Market Authorisation Date: 03 September, 2015

Treatment: Reduction of the risk of stroke in patients with acute ischemic stroke or high-risk transient ischemic attack

Dosage: TABLET;ORAL

How can I launch a generic of BRILINTA before it's drug patent expiration?
More Information on Dosage

BRILINTA family patents

Family Patents

10. Briviact patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6784197 UCB INC 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
Feb, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Aug 27, 2024
New Chemical Entity Exclusivity(NCE) May 12, 2021

Drugs and Companies using BRIVARACETAM ingredient

NCE-1 date: 12 May, 2020

Market Authorisation Date: 12 May, 2016

Treatment: Treatment of partial-onset seizures in patients 4 years of age and older

Dosage: TABLET;ORAL; SOLUTION;INTRAVENOUS; SOLUTION;ORAL

How can I launch a generic of BRIVIACT before it's drug patent expiration?
More Information on Dosage

BRIVIACT family patents

Family Patents

11. Cabenuva Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6838464 VIIV HLTHCARE 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agents
Feb, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Jan 21, 2026
New Patient Population(NPP) Mar 29, 2025
New Dosing Schedule(D-184) Jan 31, 2025

Drugs and Companies using CABOTEGRAVIR; RILPIVIRINE ingredient

NCE-1 date: 21 January, 2025

Market Authorisation Date: 21 January, 2021

Treatment: NA

Dosage: SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage

CABENUVA KIT family patents

Family Patents

12. Cleviprex patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5856346 CHIESI Short-acting dihydropyridines
Jan, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Aug 01, 2013

Drugs and Companies using CLEVIDIPINE ingredient

NCE-1 date: 01 August, 2012

Market Authorisation Date: 01 August, 2008

Treatment: Cleviprex is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable

Dosage: EMULSION;INTRAVENOUS

How can I launch a generic of CLEVIPREX before it's drug patent expiration?
More Information on Dosage

CLEVIPREX family patents

Family Patents

13. Descovy patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6703396 GILEAD SCIENCES INC Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
Mar, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-285) Sep 28, 2024
Orphan Drug Exclusivity(ODE-284) Sep 28, 2024
Orphan Drug Exclusivity(ODE-457) Jan 07, 2029
New Chemical Entity Exclusivity(NCE) Nov 05, 2020
New Patient Population(NPP) Sep 28, 2020
New Indication(I-812) Oct 03, 2022

Drugs and Companies using EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE ingredient

NCE-1 date: 06 November, 2019

Market Authorisation Date: 07 January, 2022

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of DESCOVY before it's drug patent expiration?
More Information on Dosage

DESCOVY family patents

Family Patents

14. Exondys 51 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9416361 SAREPTA THERAPS INC Splice-region antisense composition and method
May, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Sep 19, 2023
New Chemical Entity Exclusivity(NCE) Sep 19, 2021
Orphan Drug Exclusivity(ODE-122) Sep 19, 2023

Drugs and Companies using ETEPLIRSEN ingredient

NCE-1 date: 19 September, 2020

Market Authorisation Date: 19 September, 2016

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

EXONDYS 51 family patents

Family Patents

15. Farydak patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6552065 SECURA Deacetylase inhibitors
Aug, 2021

(2 years ago)

US6833384 SECURA Deacetylase inhibitors
Sep, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Feb 23, 2020
Orphan Drug Exclusivity(ODE) Feb 23, 2022
Orphan Drug Exclusivity(ODE-89) Feb 23, 2022

Drugs and Companies using PANOBINOSTAT LACTATE ingredient

NCE-1 date: 23 February, 2019

Market Authorisation Date: 23 February, 2015

Treatment: Treatment of multiple myeloma, in combination with bortezomib and dexamethasone

Dosage: CAPSULE;ORAL

More Information on Dosage

FARYDAK family patents

Family Patents

16. Flonase Sensimist Allergy Relief patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7101866 HALEON US HOLDINGS Anti-inflammatory androstane derivative
Aug, 2021

(2 years ago)

Drugs and Companies using FLUTICASONE FUROATE ingredient

Market Authorisation Date: 02 August, 2016

Treatment: Otc use: allergy symptom reliever; Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies; Nasal congestion, runny nose, sneezing, itchy nose, and (itchy water eyes ...

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

FLONASE SENSIMIST ALLERGY RELIEF family patents

Family Patents

17. Gadavist patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5980864 BAYER HLTHCARE 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them
Nov, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-801) Jul 12, 2022
New Indication(I-688) Jun 11, 2017
New Chemical Entity Exclusivity(NCE) Mar 14, 2016
New Indication(I-731) Apr 27, 2019

Drugs and Companies using GADOBUTROL ingredient

NCE-1 date: 15 March, 2015

Market Authorisation Date: 18 December, 2013

Treatment: Contrast agent for magnetic resonance imaging

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

GADAVIST family patents

Family Patents

18. Genvoya patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6703396 GILEAD SCIENCES INC Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
Mar, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Sep 25, 2020
New Dosing Schedule(D-173) Dec 10, 2021
New Chemical Entity Exclusivity(NCE) Nov 05, 2020

Drugs and Companies using COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE ingredient

NCE-1 date: 06 November, 2019

Market Authorisation Date: 05 November, 2015

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of GENVOYA before it's drug patent expiration?
More Information on Dosage

GENVOYA family patents

Family Patents

19. Juluca patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6838464 VIIV HLTHCARE 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agents
Feb, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Aug 12, 2018
New Combination(NC) Nov 21, 2020

Drugs and Companies using DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE ingredient

NCE-1 date: 12 August, 2017

Market Authorisation Date: 21 November, 2017

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of JULUCA before it's drug patent expiration?
More Information on Dosage

JULUCA family patents

Family Patents

20. Lybalvi patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7956187 ALKERMES INC Method for decreasing opioid metabolism
Oct, 2021

(2 years ago)

US8252929 ALKERMES INC 8-carboxamido-2,6-methano-3-benzazocines
Oct, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) May 28, 2026

Drugs and Companies using OLANZAPINE; SAMIDORPHAN L-MALATE ingredient

NCE-1 date: 28 May, 2025

Market Authorisation Date: 28 May, 2021

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

LYBALVI family patents

Family Patents

21. Nuplazid patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6815458 ACADIA PHARMS INC Azacyclic compounds
Mar, 2021

(3 years ago)

US6756393 ACADIA PHARMS INC Azacyclic compounds
Mar, 2021

(3 years ago)

US9296694 ACADIA PHARMS INC Azacyclic compounds
Mar, 2021

(3 years ago)

US7115634 ACADIA PHARMS INC 4-aminopiperidine and their use as a medicine
Oct, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Apr 29, 2021

Drugs and Companies using PIMAVANSERIN TARTRATE ingredient

NCE-1 date: 29 April, 2020

Market Authorisation Date: 28 June, 2018

Treatment: Treatment of psychosis

Dosage: TABLET;ORAL; CAPSULE;ORAL

How can I launch a generic of NUPLAZID before it's drug patent expiration?
More Information on Dosage

NUPLAZID family patents

Family Patents

22. Odefsey patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6838464 GILEAD SCIENCES INC 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agents
Feb, 2021

(3 years ago)

US6703396 GILEAD SCIENCES INC Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
Mar, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Nov 05, 2020
M(M-207) Aug 21, 2020
M(M-206) Aug 21, 2020

Drugs and Companies using EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE ingredient

NCE-1 date: 06 November, 2019

Market Authorisation Date: 01 March, 2016

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of ODEFSEY before it's drug patent expiration?
More Information on Dosage

ODEFSEY family patents

Family Patents

23. Onpattro patents expiration

Can you believe ONPATTRO received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8895721 ALNYLAM PHARMS INC RNA interference mediating small RNA molecules
Mar, 2021

(3 years ago)

US8362231 ALNYLAM PHARMS INC RNA interference mediating small RNA molecules
Mar, 2021

(3 years ago)

US8372968 ALNYLAM PHARMS INC RNA interference mediating small RNA molecules
Mar, 2021

(3 years ago)

US8552171 ALNYLAM PHARMS INC RNA sequence-specific mediators of RNA interference
Mar, 2021

(3 years ago)

US8895718 ALNYLAM PHARMS INC RNA interference mediating small RNA molecules
Mar, 2021

(3 years ago)

US9567582 ALNYLAM PHARMS INC RNA interference mediating small RNA molecules
Mar, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-197) Aug 10, 2025
New Chemical Entity Exclusivity(NCE) Aug 10, 2023

Drugs and Companies using PATISIRAN SODIUM ingredient

NCE-1 date: 10 August, 2022

Market Authorisation Date: 10 August, 2018

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

ONPATTRO family patents

Family Patents

24. Oriahnn (copackaged) patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6872728 ABBVIE Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
Jan, 2021

(3 years ago)

US7462625 ABBVIE Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
Jan, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Jul 23, 2023
New Product(NP) May 29, 2023

Drugs and Companies using ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM ingredient

NCE-1 date: 23 July, 2022

Market Authorisation Date: 29 May, 2020

Treatment: Management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids)

Dosage: CAPSULE;ORAL

How can I launch a generic of ORIAHNN (COPACKAGED) before it's drug patent expiration?
More Information on Dosage

ORIAHNN (COPACKAGED) family patents

Family Patents

25. Orilissa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7462625 ABBVIE Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
Jan, 2021

(3 years ago)

US6872728 ABBVIE Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
Jan, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Jul 23, 2023

Drugs and Companies using ELAGOLIX SODIUM ingredient

NCE-1 date: 23 July, 2022

Market Authorisation Date: 23 July, 2018

Treatment: Management of moderate to severe pain associated with endometriosis

Dosage: TABLET;ORAL

How can I launch a generic of ORILISSA before it's drug patent expiration?
More Information on Dosage

ORILISSA family patents

Family Patents

26. Pradaxa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6087380 BOEHRINGER INGELHEIM Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
Dec, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jun 21, 2024
Pediatric Exclusivity(PED) Dec 21, 2024

Drugs and Companies using DABIGATRAN ETEXILATE MESYLATE ingredient

Market Authorisation Date: 21 June, 2021

Treatment: Reduce the risk of recurrence of venous thrombotic disease

Dosage: PELLETS;ORAL; CAPSULE;ORAL

How can I launch a generic of PRADAXA before it's drug patent expiration?
More Information on Dosage

PRADAXA family patents

Family Patents

27. Promacta Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7473686 NOVARTIS Thrombopoietin mimetics
May, 2021

(2 years ago)

US7452874 NOVARTIS Thrombopoietin mimetics
May, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
ODE*(ODE*) Nov 16, 2025
New Dosing Schedule(D-149) Jun 11, 2018
New Indication(I-711) Jun 11, 2018
Orphan Drug Exclusivity(ODE) Aug 26, 2021
Pediatric Exclusivity(PED) Feb 26, 2022
Orphan Drug Exclusivity(ODE-74) Aug 26, 2021

Drugs and Companies using ELTROMBOPAG OLAMINE ingredient

Market Authorisation Date: 27 September, 2018

Treatment: Treatment of thrombocytopenia in patients with chronic hepatitis c to allow the initiation and maintenance of interferon-based therapy

Dosage: FOR SUSPENSION;ORAL

How can I launch a generic of PROMACTA KIT before it's drug patent expiration?
More Information on Dosage

PROMACTA KIT family patents

Family Patents

28. Selzentry patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7576097 VIIV HLTHCARE Tropane derivatives useful in therapy
May, 2021

(2 years ago)

US6667314 VIIV HLTHCARE Tropane derivatives useful in therapy
Aug, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) May 28, 2013
New Strength(NS) Nov 04, 2019
New Chemical Entity Exclusivity(NCE) Aug 06, 2012

Drugs and Companies using MARAVIROC ingredient

NCE-1 date: 07 August, 2011

Market Authorisation Date: 04 November, 2016

Treatment: Method of treating patients infected with ccr5-tropic hiv-1

Dosage: TABLET;ORAL; SOLUTION;ORAL

How can I launch a generic of SELZENTRY before it's drug patent expiration?
More Information on Dosage

SELZENTRY family patents

Family Patents

29. Symtuza patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6703396 JANSSEN PRODS Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
Mar, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Nov 05, 2020
New Combination(NC) Jul 17, 2021

Drugs and Companies using COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE ingredient

NCE-1 date: 06 November, 2019

Market Authorisation Date: 17 July, 2018

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of SYMTUZA before it's drug patent expiration?
More Information on Dosage

SYMTUZA family patents

Family Patents

30. Trelegy Ellipta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7101866 GLAXOSMITHKLINE Anti-inflammatory androstane derivative
Aug, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Dec 18, 2018
New Indication(I-775) Apr 24, 2021
New Indication(I-843) Sep 09, 2023
New Strength(NS) Sep 09, 2023

Drugs and Companies using FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE ingredient

NCE-1 date: 18 December, 2017

Market Authorisation Date: 18 September, 2017

Treatment: Use of fluticasone furoate for the treatment of an inflammatory or allergic conditions, including chronic obstructive pulmonary disease and asthma

Dosage: POWDER;INHALATION

More Information on Dosage

TRELEGY ELLIPTA family patents

Family Patents

31. Truvada patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6703396 GILEAD Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
Mar, 2021

(3 years ago)

Drugs and Companies using EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE ingredient

Market Authorisation Date: 10 March, 2016

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of TRUVADA before it's drug patent expiration?
More Information on Dosage

TRUVADA family patents

Family Patents

32. Vyleesi (autoinjector) patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6579968 PALATIN TECHNOLOGIES Compositions and methods for treatment of sexual dysfunction
Jun, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Jun 21, 2024

Drugs and Companies using BREMELANOTIDE ACETATE ingredient

NCE-1 date: 22 June, 2023

Market Authorisation Date: 21 June, 2019

Treatment: NA

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

VYLEESI (AUTOINJECTOR) family patents

Family Patents

33. Vyondys 53 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9416361 SAREPTA THERAPS INC Splice-region antisense composition and method
May, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-280) Dec 12, 2026
New Chemical Entity Exclusivity(NCE) Dec 12, 2024

Drugs and Companies using GOLODIRSEN ingredient

NCE-1 date: 13 December, 2023

Market Authorisation Date: 12 December, 2019

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

VYONDYS 53 family patents

Family Patents

34. Xenleta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6753445 NABRIVA Pleuromutilin derivatives having antibacterial activity
Jul, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Aug 19, 2024
Generating Antibiotic Incentives Now(GAIN) Aug 19, 2029

Drugs and Companies using LEFAMULIN ACETATE ingredient

NCE-1 date: 19 August, 2028

Market Authorisation Date: 19 August, 2019

Treatment: Treatment of adults with community-acquired bacterial pneumonia caused by susceptible microorganisms

Dosage: SOLUTION;INTRAVENOUS; TABLET;ORAL

More Information on Dosage

XENLETA family patents

Family Patents

35. Zontivity patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7235567 XSPIRE PHARMA Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
Jun, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) May 08, 2019

Drugs and Companies using VORAPAXAR SULFATE ingredient

NCE-1 date: 08 May, 2018

Market Authorisation Date: 08 May, 2014

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

ZONTIVITY family patents

Family Patents

36. Zydelig patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8492389 GILEAD SCIENCES INC Inhibitors of human phosphatidylinositol 3-kinase delta
Apr, 2021

(3 years ago)

US6800620 GILEAD SCIENCES INC Inhibitors of human phosphatidylinositol 3-kinase delta
Apr, 2021

(3 years ago)

US8637533 GILEAD SCIENCES INC Inhibitors of human phosphatidylinositol 3-kinase delta
Apr, 2021

(3 years ago)

US8138195 GILEAD SCIENCES INC Inhibitors of human phosphatidylinositol 3-kinase delta
Apr, 2021

(3 years ago)

US6949535 GILEAD SCIENCES INC Inhibitors of human phosphatidyl-inositol 3-kinase delta
Apr, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Jul 23, 2021
New Chemical Entity Exclusivity(NCE) Jul 23, 2019
Orphan Drug Exclusivity(ODE-70) Jul 23, 2021
Orphan Drug Exclusivity(ODE-71) Jul 23, 2021

Drugs and Companies using IDELALISIB ingredient

NCE-1 date: 23 July, 2018

Market Authorisation Date: 23 July, 2014

Treatment: A method of disrupting leukocyte function, including as an inhibitor of pi3kdelta kinase; For the treatment of patients with relapsed chronic lymphocytic leukemia

Dosage: TABLET;ORAL

How can I launch a generic of ZYDELIG before it's drug patent expiration?
More Information on Dosage

ZYDELIG family patents

Family Patents

37. Zykadia patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7153964 NOVARTIS Pyrimidine compounds
Feb, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-145) May 26, 2024
M(M-199) May 26, 2020
New Chemical Entity Exclusivity(NCE) Apr 29, 2019
Orphan Drug Exclusivity(ODE) May 26, 2024
Orphan Drug Exclusivity(ODE-66) Apr 29, 2021

Drugs and Companies using CERITINIB ingredient

NCE-1 date: 29 April, 2018

Market Authorisation Date: 29 April, 2014

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

ZYKADIA family patents

Family Patents

38. Zyvox patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6559305 PFIZER Linezolid—crystal form II
Jan, 2021

(3 years ago)

Drugs and Companies using LINEZOLID ingredient

Market Authorisation Date: 18 April, 2000

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of ZYVOX before it's drug patent expiration?
More Information on Dosage

ZYVOX family patents

Family Patents

List of large molecules

1. List of Zactran large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US5985844 NA Homoerythromycin A derivatives modified at the 4"-and 8A-positions
Jan, 2021

(3 years ago)

Ingredients: GAMITHROMYCIN

2. List of Soliris large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6355245 NA C5-specific antibodies for the treatment of inflammatory diseases
Mar, 2021

(3 years ago)

Ingredients: ECULIZUMAB

3. List of Flucelvax large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6656720 NA Animal cells and processes for the replication of influenza viruses
Apr, 2021

(3 years ago)

Ingredients: INFLUENZE VIRUS VACCINE

4. List of Prolia large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6740522 NA Antibodies against ligand for receptor activator of NF-kB
Sep, 2021

(2 years ago)

Ingredients: DENOSUMAB

5. List of Entyvio large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US7147851 NA Humanized immunoglobulin reactive with α4β7 integrin
Sep, 2021

(2 years ago)

Ingredients: VEDOLIZUMAB

6. List of Lucentis large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6716602 GENENTECH, INC. Metabolic rate shifts in fermentations expressing recombinant proteins
Nov, 2021

(2 years ago)

Ingredients: RANIBIZUMAB

7. List of Gazyva large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6602684 NA Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Nov, 2021

(2 years ago)

Ingredients: OBINUTUZUMAB